Page last updated: 2024-10-24

carbamazepine and Pulmonary Disease, Chronic Obstructive

carbamazepine has been researched along with Pulmonary Disease, Chronic Obstructive in 1 studies

Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.

Pulmonary Disease, Chronic Obstructive: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.

Research Excerpts

ExcerptRelevanceReference
" We present a case of serotonin syndrome, which was precipitated by this medicine in a patient who had been predisposed by long-term treatment with sertraline, a selective serotonin reuptake inhibitor."7.78Fatal serotonin syndrome precipitated by oxcarbazepine in a patient using an selective serotonin reuptake inhibitor. ( Dardis, C; Ly, V; Omoregie, E, 2012)
" We present a case of serotonin syndrome, which was precipitated by this medicine in a patient who had been predisposed by long-term treatment with sertraline, a selective serotonin reuptake inhibitor."3.78Fatal serotonin syndrome precipitated by oxcarbazepine in a patient using an selective serotonin reuptake inhibitor. ( Dardis, C; Ly, V; Omoregie, E, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dardis, C1
Omoregie, E1
Ly, V1

Other Studies

1 other study available for carbamazepine and Pulmonary Disease, Chronic Obstructive

ArticleYear
Fatal serotonin syndrome precipitated by oxcarbazepine in a patient using an selective serotonin reuptake inhibitor.
    The neurologist, 2012, Volume: 18, Issue:4

    Topics: Aged, 80 and over; Analgesics; Antihypertensive Agents; Atrial Fibrillation; Bronchodilator Agents;

2012